Organovo (NASDAQ:ONVO) Stock Crosses Below Fifty Day Moving Average – Time to Sell?

Organovo Holdings, Inc. (NASDAQ:ONVO) passed below its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $4.74 and traded as low as $2.02. Organovo shares last traded at $2.17, with a volume of 66,790 shares.

Wall Street Analyst Weigh In

Separately, StockNews.com began coverage on Organovo in a report on Friday. They issued a “sell” rating for the company.

Organovo Trading Up 1.4 %

The stock has a 50-day simple moving average of $4.74 and a 200 day simple moving average of $4.99. The stock has a market capitalization of $3.69 million, a price-to-earnings ratio of -2.55 and a beta of 1.13.

Organovo (NASDAQ:ONVO) last announced its quarterly earnings data on Wednesday, February 19th. The medical research company reported ($2.28) EPS for the quarter, beating analysts’ consensus estimates of ($2.52) by $0.24. Organovo had a negative net margin of 10,151.64% and a negative return on equity of 346.26%. The firm had revenue of $0.02 million for the quarter, compared to the consensus estimate of $0.05 million. Sell-side analysts expect that Organovo Holdings, Inc. will post -0.77 earnings per share for the current fiscal year.

Organovo Company Profile

Organovo Holdings, Inc, a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture.